Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

Koerper, Sixten; Weiss, Manfred; Zickler, Daniel; Wiesmann, Thomas; Zacharowski, Kai; Corman, Victor M.; Gruner, Beate; Ernst, Lucas; Spieth, Peter; Lepper, Philipp M.; Bentz, Martin; Zinn, Sebastian; Paul, Gregor; Kalbhenn, Johannes; Dollinger, Matthias M.; Rosenberger, Peter; Kirschning, Thomas; Thiele, Thomas; Appl, Thomas; Mayer, Benjamin; Schmidt, Michael; Drosten, Christian; Wulf, Hinnerk; Kruse, Jan Matthias; Jungwirth, Bettina; Seifried, Erhard; Schrezenmeier, Hubert

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

Autor(en):

Koerper, Sixten; Weiss, Manfred; Zickler, Daniel; Wiesmann, Thomas; Zacharowski, Kai; Corman, Victor M.; Gruner, Beate; Ernst, Lucas; Spieth, Peter; Lepper, Philipp M.; Bentz, Martin; Zinn, Sebastian; Paul, Gregor; Kalbhenn, Johannes; Dollinger, Matthias M.; Rosenberger, Peter; Kirschning, Thomas; Thiele, Thomas; Appl, Thomas; Mayer, Benjamin; Schmidt, Michael; Drosten, Christian; Wulf, Hinnerk; Kruse, Jan Matthias; Jungwirth, Bettina; Seifried, Erhard; Schrezenmeier, Hubert

Tübinger Autor(en):

Rosenberger, Peter

Erschienen in:

Journal of Clinical Investigation (2021-08-31), Bd. 131, Article e152264

Verlagsangabe:

Amer Soc Clinical Investigation Inc

Sprache:

Englisch

Referenz zum Volltext:

https://10.1172/JCI152264

ISSN:

1558-8238